{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:55:39Z","timestamp":1793818539719,"version":"4.6.1"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Learning Objectives<\/jats:title>\n                    <jats:p>After completing this course, the reader will be able to: Describe the events leading to the initial identification and description of Burkitt's lymphoma and the discovery of its association with the Epstein-Barr virus.Outline the WHO Classification of Burkitt's lymphoma, including the clinical and pathological variants of this lymphoma.Discuss the treatment strategies used for treating Burkitt's lymphoma.List the criteria for establishing a diagnosis of Burkitt's lymphoma and discuss the entities that may enter its differential diagnosis.<\/jats:p>\n                    <jats:p>Access and take the CME test online and receive 1 AMA PRA category 1 credit at CME.TheOncologist.com<\/jats:p>\n                    <jats:p>Burkitt's lymphoma is a highly aggressive lymphoma identified and described in the last century by Denis Burkitt in Africa, in areas endemic for malaria. Since its description in African children, it has been recognized outside areas with endemic malaria, frequently also in children as well as among individuals with an underlying immunodeficiency. Since its initial designation as Burkitt's lymphoma, this type of lymphoma and lymphomas closely resembling it have received a variety of names in different classifications of lymphomas and leukemias: undifferentiated lymphoma, Burkitt's and non-Burkitt's type in the modified Rappaport Classification, malignant lymphoma, small non-cleaved cell, Burkitt's type in the Working Formulation, Burkitt's lymphoma and high-grade B-cell lymphoma, Burkitt-like in the REAL Classification, and acute lymphoblastic leukemia, L3 type in the FAB Classification. With the publication of the WHO Classification of Haematopoietic and Lymphoid Tumors, the nomenclature of this lymphoma has come full circle, and it is once again known simply as Burkitt's lymphoma. In recent years, efforts have focused on improving therapy for this rapidly proliferating neoplasm while minimizing, to the extent possible, treatment-associated toxicity. These efforts have led to the development of high-intensity, short-duration combination chemotherapy that has proven extremely effective for a high proportion of Burkitt's lymphoma patients. The differential diagnosis of Burkitt's lymphoma is broad, and precise diagnosis based on histologic, immunophenotypic, and genetic features remains the critical first step in planning appropriate therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1634\/theoncologist.11-4-375","type":"journal-article","created":{"date-parts":[[2006,4,13]],"date-time":"2006-04-13T15:29:32Z","timestamp":1144942172000},"page":"375-383","source":"Crossref","is-referenced-by-count":279,"title":["Burkitt's Lymphoma: Clinicopathologic Features and Differential Diagnosis"],"prefix":"10.1093","volume":"11","author":[{"given":"Judith A.","family":"Ferry","sequence":"first","affiliation":[{"name":"James Homer Wright Pathology Laboratories of the Massachusetts General Hospital and the Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,4,1]]},"reference":[{"key":"2021122208180429700_R1","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/bjs.18004619704","article-title":"A sarcoma involving the jaws in African children","volume":"46","author":"Burkitt","year":"1958","journal-title":"Br J Surg"},{"key":"2021122208180429700_R2","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1002\/1097-0142(19830515)51:10<1777::AID-CNCR2820511003>3.0.CO;2-E","article-title":"The discovery of Burkitt's lymphoma","volume":"51","author":"Burkitt","year":"1983","journal-title":"Cancer"},{"key":"2021122208180429700_R3","first-page":"1","volume-title":"Burkitt's lymphoma","author":"Burkitt","year":"1970","edition":"First Edition"},{"key":"2021122208180429700_R4","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S1470-2045(04)01650-X","article-title":"Is endemic Burkitt's lymphoma an alliance between three infections and a tumour promoter","volume":"5","author":"Van den Bosch","year":"2004","journal-title":"Lancet Oncol"},{"key":"2021122208180429700_R5","first-page":"181","volume-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"Diebold","year":"2001"},{"key":"2021122208180429700_R6","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1182\/blood-2004-02-0405","article-title":"Adult Burkitt leukemia and lymphoma","volume":"104","author":"Blum","year":"2004","journal-title":"Blood"},{"key":"2021122208180429700_R7","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1016\/j.ejca.2004.09.004","article-title":"Gender and age-related differences in Burkitt lymphoma--epidemiological and clinical data from The Netherlands","volume":"40","author":"Boerma","year":"2004","journal-title":"Eur J Cancer"},{"key":"2021122208180429700_R8","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/sj.leu.2403847","article-title":"Molecular heterogeneity of sporadic adult Burkitt-type leukemia\/lymphoma as revealed by PCR and cytogenetics: correlation with morphology, immunology and clinical features","volume":"19","author":"Burmeister","year":"2005","journal-title":"Leukemia"},{"key":"2021122208180429700_R9","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00000478-200306000-00014","article-title":"Burkitt lymphoma arising in organ transplant recipients: a clinicopathologic study of five cases","volume":"27","author":"Gong","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"2021122208180429700_R10","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3109\/10428190309178777","article-title":"Post-transplant Burkitt's leukemia or lymphoma. Study of five cases treated with specific intensive therapy (PETHEMA ALL-3\/97 trial)","volume":"44","author":"Xicoy","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"2021122208180429700_R11","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0140-6736(82)92031-1","article-title":"Burkitt's lymphoma in a homosexual","volume":"1","author":"Doll","year":"1982","journal-title":"Lancet"},{"key":"2021122208180429700_R12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(82)92740-4","article-title":"Outbreak of Burkitt's-like lymphoma in homosexual men","volume":"2","author":"Ziegler","year":"1982","journal-title":"Lancet"},{"key":"2021122208180429700_R13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00001622-200409000-00003","article-title":"Treatment advances in adult Burkitt lymphoma and leukemia","volume":"16","author":"Kasamon","year":"2004","journal-title":"Curr Opin Oncol"},{"key":"2021122208180429700_R14","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0889-8588(03)00050-9","article-title":"Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma","volume":"17","author":"Knowles","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"2021122208180429700_R15","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/00001622-200209000-00009","article-title":"B-cell activation and lymphoma in patients with HIV","volume":"14","author":"Martinez-Maza","year":"2002","journal-title":"Curr Opin Oncol"},{"key":"2021122208180429700_R16","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1097\/01.pas.0000180442.87022.08","article-title":"Adult B-cell lymphomas with Burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior","volume":"29","author":"McClure","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"2021122208180429700_R17","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1182\/blood.V77.7.1516.1516","article-title":"Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association","volume":"77","author":"Shiramizu","year":"1991","journal-title":"Blood"},{"key":"2021122208180429700_R18","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.1999.17.5.1558","article-title":"Small noncleaved, non-Burkitt's (Burkit-Like) lymphoma: cytogenetics predict outcome and reflect clinical presentation","volume":"17","author":"Macpherson","year":"1999","journal-title":"J Clin Oncol"},{"key":"2021122208180429700_R19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0065-230X(08)60712-5","article-title":"Molecular pathogenesis of AIDS-related lymphomas","volume":"67","author":"Gaidano","year":"1995","journal-title":"Adv Cancer Res"},{"key":"2021122208180429700_R20","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/1097-0142(19800215)45:4<630::AID-CNCR2820450403>3.0.CO;2-5","article-title":"A randomized trial of combined modality therapy of childhood non-Hodgkin's lymphoma","volume":"45","author":"Murphy","year":"1980","journal-title":"Cancer"},{"key":"2021122208180429700_R21","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1046\/j.1365-2141.2003.04134.x","article-title":"Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience","volume":"120","author":"Cairo","year":"2003","journal-title":"Br J Haematol"},{"key":"2021122208180429700_R22","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1200\/JCO.1996.14.4.1252","article-title":"Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small non-cleaved-cell lymphoma: a Pediatric Oncology Group study","volume":"14","author":"Bowman","year":"1996","journal-title":"J Clin Oncol"},{"key":"2021122208180429700_R23","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1200\/JCO.1996.14.3.925","article-title":"Adults and children with small non-cleaved-cell lymphoma have similar excellent outcome when treated with the same chemotherapy regimen","volume":"14","author":"Magrath","year":"1996","journal-title":"J Clin Oncol"},{"key":"2021122208180429700_R24","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/annonc\/mdf253","article-title":"An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study","volume":"13","author":"Mead","year":"2002","journal-title":"Erratum appears in Ann Oncol"},{"key":"2021122208180429700_R25","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/1042819031000141301","article-title":"Modified Magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity","volume":"45","author":"Lacasce","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"2021122208180429700_R26","first-page":"574","article-title":"Outcome with hyper-CVAD and rituximab in Burkitt (BL) and Burkitt-like (BLL) leukemia\/lymphoma","volume":"22","author":"Cabanillas","year":"2002","journal-title":"Proc Am Soc Clin Oncol"},{"key":"2021122208180429700_R27","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood.V97.11.3370","article-title":"The Societe Francaise d\u2019Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia","volume":"97","author":"Patte","year":"2001","journal-title":"Blood"},{"key":"2021122208180429700_R28","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00000478-200403000-00011","article-title":"Florid granulomatous reaction in Epstein-Barr virus-positive nonendemic Burkitt lymphomas: report of four cases","volume":"28","author":"Haralambieva","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"2021122208180429700_R29","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/01.pas.0000170350.85798.f4","article-title":"Granulomatous reaction in Burkitt lymphoma: correlation with EBV positivity and clinical outcome","volume":"29","author":"Schrager","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"2021122208180429700_R30","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1309\/8WYNVUTGV9RPHUQH","article-title":"Comparative immunohistochemical analysis of pediatric Burkitt lymphoma and diffuse large B-cell lymphoma","volume":"121","author":"Frost","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"2021122208180429700_R31","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/01.pas.0000168176.71405.e5","article-title":"Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma","volume":"29","author":"Haralambieva","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"2021122208180429700_R32","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.MP.0000019577.73786.64","article-title":"The distinction between Burkitt lymphoma and diffuse large B-cell lymphoma with c-myc rearrangement","volume":"15","author":"Nakamura","year":"2002","journal-title":"Mod Pathol"},{"key":"2021122208180429700_R33","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1309\/7CEAWV0DNLLUWQTF","article-title":"Germinal center and activated B-cell profiles separate Burkitt lymphoma and diffuse large B-cell lymphoma in AIDS and non-AIDS cases","volume":"124","author":"Gormley","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"2021122208180429700_R34","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/10428190310001593120","article-title":"The spectrum of lymphoma with 8q24 aberrations: a clinical, pathological and cytogenetic study of 87 consecutive cases","volume":"45","author":"Au","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"2021122208180429700_R35","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.humpath.2005.01.004","article-title":"Transformation of follicular lymphoma to Burkitt-like lymphoma within a single lymph node","volume":"36","author":"Mukhopadhyay","year":"2005","journal-title":"Hum Pathol"},{"key":"2021122208180429700_R36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.pas.0000146027.76706.50","article-title":"Atypical Burkitt lymphoma arising from follicular lymphoma: demonstration by polymerase chain reaction following laser capture microdissection and by fluorescence in situ hybridization on paraffin-embedded tissue sections","volume":"29","author":"Tomita","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"2021122208180429700_R37","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5858\/2004-128-210-FLWABT","article-title":"Follicular lymphoma with a Burkitt translocation--predictor of an aggressive clinical course: a case report and review of the literature","volume":"128","author":"Voorhees","year":"2004","journal-title":"Arch Pathol Lab Med"},{"key":"2021122208180429700_R38","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/318533a0","article-title":"The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice","volume":"318","author":"Adams","year":"1985","journal-title":"Nature"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.11-4-375","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.11-4-375","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/11\/4\/375\/41850866\/oncolo_11_4_375.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/11\/4\/375\/41850866\/oncolo_11_4_375.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T08:33:10Z","timestamp":1640161990000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/11\/4\/375\/6397059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,1]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2006,4,1]]},"published-print":{"date-parts":[[2006,4,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.11-4-375","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.12577.470062","asserted-by":"object"}]},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2006,4,1]]},"published":{"date-parts":[[2006,4,1]]}}}